De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Inogen Toekomstige groei
Future criteriumcontroles 0/6
Inogen zal naar verwachting groeien in winst en omzet met respectievelijk 35% en 3.6% per jaar. De winst per aandeel zal naar verwachting groeien met 35.7% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting -18.3% zijn.
Belangrijke informatie
35.0%
Groei van de winst
35.7%
Groei van de winst per aandeel
Medical Equipment winstgroei | 17.5% |
Inkomstengroei | 3.6% |
Toekomstig rendement op eigen vermogen | -18.3% |
Dekking van analisten | Low |
Laatst bijgewerkt | 07 Aug 2024 |
Recente toekomstige groei-updates
Recent updates
Inogen: Upside Seems Limited After Big Move Up
Sep 24Inogen, Inc.'s (NASDAQ:INGN) Price Is Right But Growth Is Lacking After Shares Rocket 26%
Jul 16Inogen: Improving, But Still Struggling For Air
Jul 01Inogen, Inc. (NASDAQ:INGN) Stock Catapults 28% Though Its Price And Business Still Lag The Industry
May 22Inogen: New Management And A Major Competitor Exit Offer Some New Opportunities
Apr 13Inogen, Inc. (NASDAQ:INGN) Just Reported, And Analysts Assigned A US$6.50 Price Target
Mar 01Inogen, Inc. (NASDAQ:INGN) Held Back By Insufficient Growth Even After Shares Climb 25%
Feb 01Is Inogen (NASDAQ:INGN) In A Good Position To Deliver On Growth Plans?
Oct 06Inogen (NASDAQ:INGN) Is In A Strong Position To Grow Its Business
Jun 21Is Inogen, Inc. (NASDAQ:INGN) Worth US$13.3 Based On Its Intrinsic Value?
Mar 14Companies Like Inogen (NASDAQ:INGN) Can Afford To Invest In Growth
Oct 27Inogen, Inc.'s (NASDAQ:INGN) Intrinsic Value Is Potentially 64% Above Its Share Price
Sep 20Inogen: Structural, Supply Chain Headwinds Remain
Sep 13Inogen Non-GAAP EPS of -$0.02 beats by $0.31, revenue of $103.38M beats by $2.74M
Aug 04Inogen: Seasonal FCF, Tightening Margins, Supply Chain Headwinds
Jun 14At US$35.28, Is It Time To Put Inogen, Inc. (NASDAQ:INGN) On Your Watch List?
Apr 03Hammered By Supply Issues, Inogen Could Be A 2023 Comeback Story
Mar 31Is There An Opportunity With Inogen, Inc.'s (NASDAQ:INGN) 28% Undervaluation?
Mar 09Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
12/31/2026 | 357 | -37 | -9 | 35 | 3 |
12/31/2025 | 341 | -42 | -12 | 24 | 4 |
12/31/2024 | 327 | -46 | N/A | 14 | 4 |
6/30/2024 | 327 | -92 | -20 | 1 | N/A |
3/31/2024 | 322 | -97 | -26 | -2 | N/A |
12/31/2023 | 316 | -102 | -30 | -3 | N/A |
9/30/2023 | 328 | -133 | -43 | -16 | N/A |
6/30/2023 | 349 | -96 | -55 | -27 | N/A |
3/31/2023 | 369 | -90 | -50 | -26 | N/A |
12/31/2022 | 377 | -84 | -59 | -38 | N/A |
9/30/2022 | 366 | -50 | -36 | -16 | N/A |
6/30/2022 | 353 | -28 | -31 | -9 | N/A |
3/31/2022 | 351 | -20 | -20 | 3 | N/A |
12/31/2021 | 358 | -6 | 0 | 24 | N/A |
9/30/2021 | 356 | 11 | 9 | 33 | N/A |
6/30/2021 | 337 | -2 | 20 | 43 | N/A |
3/31/2021 | 307 | -5 | 19 | 39 | N/A |
12/31/2020 | 308 | -6 | 19 | 37 | N/A |
9/30/2020 | 313 | -2 | 16 | 30 | N/A |
6/30/2020 | 331 | 6 | 29 | 38 | N/A |
3/31/2020 | 360 | 14 | 36 | 43 | N/A |
12/31/2019 | 362 | 21 | 34 | 41 | N/A |
9/30/2019 | 370 | 32 | 37 | 44 | N/A |
6/30/2019 | 373 | 42 | 34 | 43 | N/A |
3/31/2019 | 369 | 46 | 35 | 46 | N/A |
12/31/2018 | 358 | 52 | 47 | 60 | N/A |
9/30/2018 | 335 | 41 | 44 | 61 | N/A |
6/30/2018 | 309 | 32 | 49 | 64 | N/A |
3/31/2018 | 276 | 26 | N/A | 60 | N/A |
12/31/2017 | 249 | 21 | N/A | 60 | N/A |
9/30/2017 | 237 | 27 | N/A | 53 | N/A |
6/30/2017 | 222 | 25 | N/A | 44 | N/A |
3/31/2017 | 212 | 24 | N/A | 39 | N/A |
12/31/2016 | 203 | 21 | N/A | 31 | N/A |
9/30/2016 | 192 | 19 | N/A | 38 | N/A |
6/30/2016 | 179 | 17 | N/A | 41 | N/A |
3/31/2016 | 168 | 13 | N/A | 37 | N/A |
12/31/2015 | 159 | 12 | N/A | 38 | N/A |
9/30/2015 | 148 | 9 | N/A | 30 | N/A |
6/30/2015 | 136 | 9 | N/A | 21 | N/A |
3/31/2015 | 123 | 7 | N/A | 23 | N/A |
12/31/2014 | 113 | 5 | N/A | 16 | N/A |
9/30/2014 | 103 | 6 | N/A | 13 | N/A |
6/30/2014 | 94 | 3 | N/A | 15 | N/A |
3/31/2014 | 83 | 1 | N/A | 9 | N/A |
12/31/2013 | 75 | 0 | N/A | 13 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachting is dat INGN de komende 3 jaar verliesgevend zal blijven.
Winst versus markt: De verwachting is dat INGN de komende 3 jaar verliesgevend zal blijven.
Hoge groeiwinsten: De verwachting is dat INGN de komende 3 jaar verliesgevend zal blijven.
Omzet versus markt: De omzet van INGN ( 3.6% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 8.7% per jaar).
Hoge groei-inkomsten: De omzet van INGN ( 3.6% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Er wordt voorspeld dat INGN binnen 3 jaar verliesgevend zal zijn.